ID   LAZ-177
AC   CVCL_GY94
SY   LAZ 177; LAZ177; HPFH-2
DR   Wikidata; Q54901985
RX   PubMed=6196781;
CC   From: Lazarus, Herbert; Dana-Farber Cancer Institute; Boston; USA.
CC   Population: African American.
CC   Sequence variation: Gene deletion; HGNC; HGNC:4827; HBB; Zygosity=Homozygous (PubMed=6196781).
CC   Sequence variation: Gene deletion; HGNC; HGNC:4829; HBD; Zygosity=Homozygous (PubMed=6196781).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129072; Hereditary persistence of fetal hemoglobin
DI   ORDO; Orphanet_46532; Hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
RX   PubMed=6196781; DOI=10.1073/pnas.80.22.6937; PMCID=PMC390101;
RA   Tuan Lo D., Feingold E., Newman M., Weissman S.M., Forget B.G.;
RT   "Different 3' end points of deletions causing delta beta-thalassemia
RT   and hereditary persistence of fetal hemoglobin: implications for the
RT   control of gamma-globin gene expression in man.";
RL   Proc. Natl. Acad. Sci. U.S.A. 80:6937-6941(1983).
//